http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100570450-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate | 2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100570450-B1 |
| titleOfInvention | Soft capsule composition of soluble lovastatin and preparation method thereof |
| abstract | The present invention is a poorly soluble hyperlipidemia treatment, lovastatin as an active ingredient, solubilized using a self-emulsifying emulsion system consisting of a hydrophilic solvent, pH adjuster, surfactant, oil, antioxidants, etc. It is related with the manufacturing method of the lovastatin containing soft capsule which greatly improved and secured stability.n n n The lovastatin-containing soft capsule according to the present invention ensures stability, maximizes the absorption rate of the drug, greatly improves bioavailability and ensures stability.n n n Hyperlipidemia treatment, lovastatin, pH adjuster, surfactant, antioxidant, self-emulsifying emulsion system, soft capsule |
| priorityDate | 2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.